Citigroup Inc Organogenesis Holdings Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Citigroup Inc holds 54,584 shares of ORGO stock, worth $210,694. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,584

Previous 17,877 205.33%

Holding current value

$210,694

Previous $50,000 212.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.42 - $3.24 $88,830 - $118,930	36,707 Added 205.33%	54,584 $156,000
Q2 2024 Aug 12, 2024	BUY	$2.28 - $3.03 $4,917 - $6,535	2,157 Added 13.72%	17,877 $50,000
Q1 2024 May 10, 2024	BUY	$2.61 - $4.49 $10,664 - $18,346	4,086 Added 35.12%	15,720 $44,000
Q4 2023 Feb 09, 2024	BUY	$1.97 - $4.21 $21,721 - $46,419	11,026 Added 1813.49%	11,634 $47,000
Q3 2023 Nov 09, 2023	SELL	$2.34 - $4.43 $47,572 - $90,061	-20,330 Reduced 97.1%	608 $1,000
Q2 2023 Aug 10, 2023	BUY	$1.9 - $4.3 $35,543 - $80,440	18,707 Added 838.5%	20,938 $69,000
Q1 2023 May 11, 2023	SELL	$1.89 - $2.93 $77,382 - $119,962	-40,943 Reduced 94.83%	2,231 $4,000
Q4 2022 Feb 09, 2023	BUY	$2.48 - $3.43 $22,374 - $30,945	9,022 Added 26.42%	43,174 $116,000
Q3 2022 Nov 10, 2022	SELL	$3.14 - $6.43 $689,509 - $1.41 Million	-219,589 Reduced 86.54%	34,152 $111,000
Q2 2022 Aug 10, 2022	BUY	$4.74 - $8.15 $776,350 - $1.33 Million	163,787 Added 182.08%	253,741 $1.24 Million
Q1 2022 May 12, 2022	SELL	$6.47 - $9.57 $1.52 Million - $2.25 Million	-235,371 Reduced 72.35%	89,954 $686,000
Q4 2021 Feb 10, 2022	BUY	$9.02 - $13.5 $1.81 Million - $2.71 Million	200,959 Added 161.59%	325,325 $3.01 Million
Q3 2021 Nov 10, 2021	BUY	$13.71 - $17.18 $1.71 Million - $2.14 Million	124,366 New	124,366 $1.77 Million

Others Institutions Holding ORGO

# of Institutions

117

Shares Held

63.2M

Call Options Held

25K

Put Options Held

23.2K

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account